Tokio Marine Asset Management CO LTD Regeneron Pharmaceuticals, Inc. Transaction History
Tokio Marine Asset Management CO LTD
- $2.55 Billion
- Q2 2025
A detailed history of Tokio Marine Asset Management CO LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Tokio Marine Asset Management CO LTD holds 3,714 shares of REGN stock, worth $2.09 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,714
Previous 15,062
75.34%
Holding current value
$2.09 Million
Previous $9.55 Million
79.6%
% of portfolio
0.08%
Previous 0.36%
Shares
29 transactions
Others Institutions Holding REGN
# of Institutions
1,417Shares Held
88.7MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.31 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.76 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.19 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.72 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.16 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $60.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...